Information Provided By:
Fly News Breaks for May 4, 2018
AMN
May 4, 2018 | 07:54 EDT
As reported previously, Baird analyst Mark Marcon downgraded AMN Healthcare to Neutral from Outperform, as he said the boost from premium rate assignments appear to be slowing. He said the current valuation appears fair, although the company remains best-in-segment with excellent long-term prospects. Marcon lowered his price target to $61 from $64 on AMN Healthcare shares.
News For AMN From the Last 2 Days
There are no results for your query AMN